(Q35046572)

6

object named as

Hideo Yagita

1 reference

6 August 2017

Marcel R M van den Brink

object named as

Marcel R M van den Brink

5

1 reference

ORCID Public Data File 2021

author name string

Kazuyoshi Takeda

2

1 reference

6 August 2017

Yoshihiro Hayakawa

3

1 reference

6 August 2017

Jacques J Peschon

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

18

1 reference

6 August 2017

1-6

1 reference

6 August 2017

1

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

How melanoma cells evade trail-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

The potential of TRAIL for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

T cells require TRAIL for optimal graft-versus-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2802%2900502-2

7 January 2021